{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Russo A"],"funding":["Regione Campania"],"pagination":["652"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9227474"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(6)"],"pubmed_abstract":["<h4>Introduction</h4>Given the impact of COVID-19 on the world healthcare system, and the efforts of the healthcare community to find prognostic factors for hospitalization, disease progression, and mortality, the aim of the present study was to investigate the prognostic impact of transaminases and bilirubin levels at admission to hospital on disease progression and mortality in COVID-19 patients.<h4>Methods</h4>Using the CoviCamp database, we performed a multicenter, observational, retrospective study involving 17 COVID-19 Units in southern Italy. We included all adult patients hospitalized for SARS-CoV-2 infection with at least one determination at hospital admission of aminotransaminases and/or total bilirubin.<h4>Results</h4>Of the 2054 patients included in the CoviCamp database, 1641"],"journal":["Pathogens (Basel, Switzerland)"],"pubmed_title":["Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study."],"pmcid":["PMC9227474"],"funding_grant_id":["POR"],"pubmed_authors":["Numis FG","Ponticiello A","Russo G","Maggi P","Salomone Megna A","Masullo A","Rescigno C","Esposito V","Gambardella M","Punzi R","Gentile I","Palladino R","On Behalf Of CoviCam Group","Sangiovanni V","Pisaturo M","Dell'Aquila G","Parrella R","Coppola N","Calabria G","Manzillo E","Russo A"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study.","description":"<h4>Introduction</h4>Given the impact of COVID-19 on the world healthcare system, and the efforts of the healthcare community to find prognostic factors for hospitalization, disease progression, and mortality, the aim of the present study was to investigate the prognostic impact of transaminases and bilirubin levels at admission to hospital on disease progression and mortality in COVID-19 patients.<h4>Methods</h4>Using the CoviCamp database, we performed a multicenter, observational, retrospective study involving 17 COVID-19 Units in southern Italy. We included all adult patients hospitalized for SARS-CoV-2 infection with at least one determination at hospital admission of aminotransaminases and/or total bilirubin.<h4>Results</h4>Of the 2054 patients included in the CoviCamp database, 1641","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jun","modification":"2025-04-04T21:41:08.102Z","creation":"2025-04-04T21:41:08.102Z"},"accession":"S-EPMC9227474","cross_references":{"pubmed":["35745506"],"doi":["10.3390/pathogens11060652"]}}